MR imaging of the breast before and after neoadjuvant treatment enhancement characteristics and t 2 signal intensity of breast cancers and breast parenchyma;MR-mammografie vor und nach neoadjuvanter systemtherapie enhancementcharakteristika und t 2-signalinintensität von mammakarzinomen und drüsenparenchym

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 182, Issue 6, 2010, Pages 493-500

  Siegmann, K C ^a   Muller K T ^b   Vogel, U ^a   Krauss, K ^a   Claussen, C D ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Klinikum Neuperlach   (Germany)

Author keywords

Breast; Chemotherapy; Diagnostic radiology; MR imaging

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; BREAST PARENCHYMA; CANCER GROWTH; CANCER REGRESSION; CLINICAL ARTICLE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BREAST; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 77953156304     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0028-1109883     Document Type: Article

References (28)

1. Kreienberg R, Kopp I, Albert U et al. Interdisziplinäre S 3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. 1. Aktualisierung 2008. München Zuckschwerdt-Verlag 2008 91
2. Huober J, Krainick-Strobel U, Kurek R et al. Neoadjuvant endocrine therapy in primary breast cancer. Clin Breast Cancer 2004 5 341-347
3. Freedman O C., Verma S, Clemons M J. Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution? Cancer Treat Rev 2005 31 1-17
4. Drew P J., Kerin M J., Hahapatra T et al. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 2001 27 617-620
5. Warren R ML, Bobrow L G., Earl H M. et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 2004 90 1349-1360
6. Segara D, Krop I E., Garber J E. et al. Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? JSurg Oncol 2007 96 474-480
7. Rosen E L., Blackwell K L., Baker J A. et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol 2003 181 1275-1282
8. Wasser K, Klein S, Junkermann H et al. Neoadjuvante Therapie des Mammakarzinoms. Welche posttherapeutischen (präoperativen) Informationen liefert die quantitative dynamische MRT? Radiologe 2007 47 421-429
9. Kim H J., Im Y H., Han B K. et al. Accuracy of MRI for estimating residual tumor size after neodajuvant chemotherapy. Acta Oncol 2007 46 996-1003
10. Bhattacharyya M, Ryan D, Carpenter R et al. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer. Br J Cancer 2008 98 289-293
11. Akazawa K, Tamaki Y, Tagushi T. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy. Breast J 2006 12 130-137
12. Yeh E, Slanztz P, Kopans D et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neadjuvuant chemotherapy for palpable breast cancer. Am J Roentgenol 2005 184 686-877
13. Londero V, Bazzocchi M, Frate C D. et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004 14 1371-1379
14. Balu-Maestro C, Chapellier C, Bleuse A et al. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 2002 72 145-152
15. Hylton N. MR Imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn Reson Imaging Clin N Am 2006 14 383-389
16. Renz D M., Baltzer P A., Kullnig P E. et al. Klinische Wertigkeit computergestützter Analysen in der MR-Mammografie. Ein Vergleich zwischen zwei Systemen und drei Untersuchern mit unterschiedlicher Erfahrung Fortschr Röntgenstr 2008 180 968-976
17. Wasser K, Klein S K., Fink C et al. Evaluation of neodjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol 2003 13 80-87
18. Yu H J., Chen J H., Mehta R S. et al. MRI measurements of tumor size and pharmocokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. JMagn Reson Imaging 2007 26 615-623
19. Pickles M D., Lowry M, Manton D J. et al. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005 91 1-10
20. Delille J P., Slanetz P J., Yeh E D. et al. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging Pilot study. Radiology 2003 228 63-69
21. Wasser K, Sinn H P., Fink C et al. Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherpy. Eur Radiol 2003 13 1213-1223
22. Fischer U, Kopka L, Grabbe E. Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapuetic approach. Radiology 1999 213 881-888
23. Fischer U. Lehratlas der MR-Mammographie. Stuttgart Thieme 2000 24
24. Therasse P, Arbuck S G., Eisenhauer E A. et al. New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. JNatl Cancer Inst 2000 92 205-216
25. Wormanns D. Radiologische Messverfahren zur Beurteilung des Therapieansprechens solider Tumoren. Radiologie up2date 2005 3 261-271
26. Rieber A, Brambs H J., Gabelmann A et al. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002 12 1711-1719
27. Martincich L, Montemurro F, De Rosa G et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004 83 67-76
28. Padhani A R., Hayes C, Assersohn L et al. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging. Radiology 2006 239 361-374